Join
Live feed
·
INSIDERFilingvia Quantisnow
Inhibrx Biosciences Inc. logo

Kayyem Jon Faiz bought $4,927,580 worth of shares (286,786 units at $17.18) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
INXB· Inhibrx Biosciences Inc.
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INXB (Inhibrx Biosciences Inc.) and more on Quantisnow.